When you examine the well-publicized boardroom missteps in companies like Theranos, Zenefits, Tesla, and Uber, it becomes increasingly clear that poor board composition was a common denominator.  This panel will provide frank perspectives from the C-suite, boardroom, and investment committee on the teachable moments from these case studies that depict why better governed companies not only make more money… but are also better at raising capital.